For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can ...
A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach ...
The film combines biotech horror elements with family drama to explore people’s fears about medical testing and the dangers ...
Plantar fasciitis has ended Egor Dëmin’s rookie season. A successful procedure has the Nets guard already looking toward the ...
A new study found that an algorithm created by UC San Francisco researchers helped improve the health of thousands of Californians and prevented dozens of deaths.
Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...
New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.
Facing the loss of his beloved rescue dog, a tech entrepreneur enlisted AI and ChatGPT to co-develop an experimental cancer vaccine.
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results